Individual patient- versus literature-based meta-analysis of survival data: Time to event and event rate at a particular time can make a difference, an example based on head and neck cancer

Controlled Clinical Trials

Volumn 22, Issue 5, 2001, Pages 538-547

  Duchateau, Luc ^a   Pignon, Jean Pierre ^b   Bijnens, Luc ^a   Bertin, Sylvie ^b   Bourhis, Jean ^b   Sylvester, Richard ^a  

^a EORTC DATA CENTER   (Belgium)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Hazard ratio; Head and neck cancer; Individual patient data meta analysis; Literature based meta analysis; Odds ratio

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INTERMETHOD COMPARISON; LITERATURE; META ANALYSIS; METHODOLOGY; MORTALITY; PATIENT; RISK; STATISTICAL ANALYSIS; SURVIVAL; TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; HEAD AND NECK NEOPLASMS; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0034816161     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(01)00152-0     Document Type: Article

References (16)

1. From science to practice. Meta-analyses using individual patient data are needed
2. Issues of efficiency in combining proportions of deaths from several clinical trials
3. Meta-analyses of the literature or of individual patient data: Is there a difference?
4. Systematic review using individual patient data: A map for the minefields?
5. Role of thoracic radiotherapy in limited-stage small cell lung cancer: Quantitative review based on literature versus meta-analysis based on individual data
6. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data
7. An overview of randomized controlled clinical trials of adjuvant chemotherapy in head and neck cancer
8. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials
9. Adjuvant chemotherapy for head and neck cancer
10. Meta-analyses in head and neck squamous cell carcinoma: What is the role of chemotherapy?
11. Beta-blockade during and after myocardial infarction: An overview of the randomized trials
12. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
13. Estimating number of events from the Kaplan Meier curve for incorporation in a literature based meta-analysis: What you don't see you can't get!
14. Statistical aspects of the analysis of data from retrospective studies of disease
15. Investigating underlying risk as a source of heterogeneity in meta-analysis
16. Individual patient data meta-analysis of randomized anti-epileptic drug monotherapy trials